Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Survival Analysis Using the Covid-death Mean-imputation (CoDMI) Algorithm: A First Clinical Application in Radiation Oncology

FRANCESCA DE FELICE, LUCA MAZZONI, DANIELA MUSIO, VINCENZO TOMBOLINI and FRANCO MORICONI
In Vivo November 2022, 36 (6) 2986-2992; DOI: https://doi.org/10.21873/invivo.13043
FRANCESCA DE FELICE
1Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: francesca.defelice@uniroma1.it
LUCA MAZZONI
2Department of Statistics, Computer Science, Applications, University of Florence, Florence, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIELA MUSIO
1Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VINCENZO TOMBOLINI
1Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCO MORICONI
3Department of Economics, University of Perugia, Perugia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 36 no. 6 2986-2992
DOI 
https://doi.org/10.21873/invivo.13043
PubMed 
36309383

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received June 25, 2022
  • Revision received August 21, 2022
  • Accepted August 29, 2022
  • Published online October 29, 2022.

Copyright & Usage 
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. FRANCESCA DE FELICE1⇑,
  2. LUCA MAZZONI2,
  3. DANIELA MUSIO1,
  4. VINCENZO TOMBOLINI1 and
  5. FRANCO MORICONI3
  1. 1Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Rome, Italy;
  2. 2Department of Statistics, Computer Science, Applications, University of Florence, Florence, Italy;
  3. 3Department of Economics, University of Perugia, Perugia, Italy
  1. Correspondence to: Francesca De Felice, Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Viale Regina Elena 326, 00161 Rome, Italy. Tel: +39 0649973411, Fax: +39 0649973411, e-mail: francesca.defelice{at}uniroma1.it
View Full Text
PreviousNext
Back to top

In this issue

In Vivo: 36 (6)
In Vivo
Vol. 36, Issue 6
November-December 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Survival Analysis Using the Covid-death Mean-imputation (CoDMI) Algorithm: A First Clinical Application in Radiation Oncology
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Survival Analysis Using the Covid-death Mean-imputation (CoDMI) Algorithm: A First Clinical Application in Radiation Oncology
FRANCESCA DE FELICE, LUCA MAZZONI, DANIELA MUSIO, VINCENZO TOMBOLINI, FRANCO MORICONI
In Vivo Nov 2022, 36 (6) 2986-2992; DOI: 10.21873/invivo.13043

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Survival Analysis Using the Covid-death Mean-imputation (CoDMI) Algorithm: A First Clinical Application in Radiation Oncology
FRANCESCA DE FELICE, LUCA MAZZONI, DANIELA MUSIO, VINCENZO TOMBOLINI, FRANCO MORICONI
In Vivo Nov 2022, 36 (6) 2986-2992; DOI: 10.21873/invivo.13043
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Evaluation of TET Family Gene Expression and 5-Hydroxymethylcytosine as Potential Epigenetic Markers in Non-small Cell Lung Cancer
  • Automated Non-coplanar Volumetric Modulated Arc Therapy Planning for Maxillary Sinus Carcinoma
  • The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER
Show more Clinical Studies

Similar Articles

Keywords

  • Survival
  • CoDMI algorithm
  • COVID-19
  • Kaplan-Meier
  • Cancer
In Vivo

© 2023 In Vivo

Powered by HighWire